VEN Stock Overview
Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
VEN passed our risk checks.
Ventas, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$40.56 |
52 Week High | US$45.87 |
52 Week Low | US$37.17 |
Beta | 1.29 |
1 Month Change | 1.60% |
3 Month Change | -6.93% |
1 Year Change | -3.66% |
3 Year Change | -11.88% |
5 Year Change | -24.40% |
Change since IPO | 115.06% |
Recent News & Updates
Recent updates
Shareholder Returns
VEN | DE Health Care REITs | DE Market | |
---|---|---|---|
7D | 3.8% | 0% | 0% |
1Y | -3.7% | 0% | 0% |
Price Volatility
VEN volatility | |
---|---|
VEN Average Weekly Movement | 3.0% |
Health Care REITs Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in DE Market | 0% |
10% least volatile stocks in DE Market | 0% |
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 486 | Deb Cafaro | www.ventasreit.com |
Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company’s growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties.
Ventas, Inc. Fundamentals Summary
VEN fundamental statistics | |
---|---|
Market cap | €16.53b |
Earnings (TTM) | -€38.29m |
Revenue (TTM) | €4.20b |
3.9x
P/S Ratio-428.7x
P/E RatioIs VEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VEN income statement (TTM) | |
---|---|
Revenue | US$4.50b |
Cost of Revenue | US$2.54b |
Gross Profit | US$1.96b |
Other Expenses | US$2.00b |
Earnings | -US$40.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
Earnings per share (EPS) | -0.10 |
Gross Margin | 43.53% |
Net Profit Margin | -0.91% |
Debt/Equity Ratio | 137.0% |
How did VEN perform over the long term?
See historical performance and comparison